The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
Authors
Keywords
-
Journal
Therapeutic Advances in Endocrinology and Metabolism
Volume 12, Issue -, Pages 204201882198923
Publisher
SAGE Publications
Online
2021-01-27
DOI
10.1177/2042018821989238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
- (2020) Georgios S. Papaetis et al. CLINICAL DRUG INVESTIGATION
- GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites
- (2020) Zhihua Sun et al. International Journal of Endocrinology
- The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls
- (2019) H Kahal et al. GYNECOLOGICAL ENDOCRINOLOGY
- Adipose Insulin Resistance in Normal-Weight Polycystic Ovary Syndrome Women
- (2019) Daniel A Dumesic et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
- (2019) Alison J. Dawson et al. Frontiers in Endocrinology
- Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients
- (2019) Liang Tang et al. CLINICAL ENDOCRINOLOGY
- Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19
- (2019) Qiong Wang et al. CELL CYCLE
- Sitagliptin decreases visceral fat and blood glucoses in women with polycystic ovarian syndrome
- (2019) Jessica K Devin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
- (2019) Simona Ferjan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
- (2019) Xin Tao et al. Journal of Ovarian Research
- DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY
- (2018) Simona Ferjan et al. Endocrine Practice
- Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
- (2018) Vesna Salamun et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- (2018) Helena J. Teede et al. FERTILITY AND STERILITY
- Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells
- (2018) Yuki Nishiyama et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
- (2018) Tao Tao et al. BMC Endocrine Disorders
- Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats
- (2018) Fang Wang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress
- (2018) Yaojing Jiang et al. Frontiers in Pharmacology
- Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study
- (2017) Simona Ferjan et al. Metabolic Syndrome and Related Disorders
- Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight
- (2017) L López-Ferreras et al. MOLECULAR PSYCHIATRY
- Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial
- (2017) Malin Nylander et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
- (2017) Mojca Jensterle et al. BMC Endocrine Disorders
- Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
- (2016) C. Guo et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas
- (2016) M. M. Smits et al. DIABETES OBESITY & METABOLISM
- Refining diagnostic features in PCOS to optimize health outcomes
- (2016) Jacqueline A. Boyle et al. Nature Reviews Endocrinology
- Effects of Exenatide on Metabolic Changes, Sexual Hormones, Inflammatory Cytokines, Adipokines, and Weight Change in a DHEA-Treated Rat Model
- (2016) Lingjun Sun et al. Reproductive Sciences
- Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways
- (2016) Imre Farkas et al. Frontiers in Cellular Neuroscience
- A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries
- (2015) Mitra Niafar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- GLP-1 Receptor Agonists
- (2015) Curtis Triplitt et al. DIABETES EDUCATOR
- GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats
- (2015) Verónica Outeiriño-Iglesias et al. ENDOCRINOLOGY
- Liraglutide and obesity: a review of the data so far
- (2015) Ellen Ladenheim Drug Design Development and Therapy
- Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
- (2015) Mojca Jensterle et al. Journal of Ovarian Research
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome
- (2014) Mojca Jensterle et al. ENDOCRINE RESEARCH
- The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
- (2014) Christina B. Rasmussen et al. Frontiers in Endocrinology
- Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
- (2013) H. Kahal et al. CLINICAL ENDOCRINOLOGY
- The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications
- (2013) S. Madsbad DIABETES OBESITY & METABOLISM
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
- (2012) A. R. Meloni et al. DIABETES OBESITY & METABOLISM
- Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
- (2012) Fang Zhang et al. International Journal of Medical Sciences
- Incretin Effects on -Cell Function, Replication, and Mass: The human perspective
- (2011) A. J. Garber DIABETES CARE
- Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats
- (2011) Brian Chen et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- (2011) Mark O. Goodarzi et al. Nature Reviews Endocrinology
- Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys
- (2011) Ning Xu et al. PLoS One
- GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet
- (2010) Edwin T. Parlevliet et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
- (2010) A. D. Dobrian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
- (2009) W. A. March et al. HUMAN REPRODUCTION
- Incretin levels in polycystic ovary syndrome
- (2008) Jana Vrbikova et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome
- (2008) Karen Elkind-Hirsch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now